BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24784775)

  • 1. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.
    West MA; Loughney L; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
    Eur J Surg Oncol; 2014 Nov; 40(11):1421-8. PubMed ID: 24784775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study.
    West MA; Loughney L; Lythgoe D; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
    Br J Anaesth; 2015 Feb; 114(2):244-51. PubMed ID: 25274049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot study.
    West MA; Loughney L; Lythgoe D; Barben CP; Adams VL; Bimson WE; Grocott MP; Jack S; Kemp GJ
    PLoS One; 2014; 9(12):e111526. PubMed ID: 25478898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial.
    Loughney L; West MA; Kemp GJ; Rossiter HB; Burke SM; Cox T; Barben CP; Mythen MG; Calverley P; Palmer DH; Grocott MP; Jack S
    Trials; 2016 Jan; 17():24. PubMed ID: 26762365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    West MA; Astin R; Moyses HE; Cave J; White D; Levett DZH; Bates A; Brown G; Grocott MPW; Jack S
    Acta Oncol; 2019 May; 58(5):588-595. PubMed ID: 30724668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
    West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
    Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary exercise testing for the prediction of morbidity risk after rectal cancer surgery.
    West MA; Parry MG; Lythgoe D; Barben CP; Kemp GJ; Grocott MP; Jack S
    Br J Surg; 2014 Aug; 101(9):1166-72. PubMed ID: 24916313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
    Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
    Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
    Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for postoperative morbidity and tumour response after neoadjuvant chemoradiation followed by resection for rectal cancer.
    Berkel AE; Woutersen DP; van der Palen J; Klaase JM
    J Gastrointest Surg; 2014 Sep; 18(9):1648-57. PubMed ID: 24939597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
    Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
    World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.
    West MA; Loughney L; Ambler G; Dimitrov BD; Kelly JJ; Mythen MG; Sturgess R; Calverley PM; Kendrick A; Grocott MP; Jack S
    BMC Cancer; 2016 Sep; 16(1):710. PubMed ID: 27589870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
    Hofheinz RD; Wenz F; Post S; Matzdorff A; Laechelt S; Hartmann JT; Müller L; Link H; Moehler M; Kettner E; Fritz E; Hieber U; Lindemann HW; Grunewald M; Kremers S; Constantin C; Hipp M; Hartung G; Gencer D; Kienle P; Burkholder I; Hochhaus A
    Lancet Oncol; 2012 Jun; 13(6):579-88. PubMed ID: 22503032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
    Swellengrebel HA; Bosch SL; Cats A; Vincent AD; Dewit LG; Verwaal VJ; Nagtegaal ID; Marijnen CA
    Radiother Oncol; 2014 Jul; 112(1):44-51. PubMed ID: 25018000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery.
    Jack S; West MA; Raw D; Marwood S; Ambler G; Cope TM; Shrotri M; Sturgess RP; Calverley PM; Ottensmeier CH; Grocott MP
    Eur J Surg Oncol; 2014 Oct; 40(10):1313-20. PubMed ID: 24731268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
    Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
    Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary exercise testing for preoperative risk assessment before pancreaticoduodenectomy for cancer.
    Junejo MA; Mason JM; Sheen AJ; Bryan A; Moore J; Foster P; Atkinson D; Parker MJ; Siriwardena AK
    Ann Surg Oncol; 2014 Jun; 21(6):1929-36. PubMed ID: 24477709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between cardiopulmonary exercise testing and postoperative outcomes in patients with lung cancer undergoing lung resection surgery: A systematic review and meta-analysis.
    Arbee-Kalidas N; Moutlana HJ; Moodley Y; Kebalepile MM; Motshabi Chakane P
    PLoS One; 2023; 18(12):e0295430. PubMed ID: 38060569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.